SCHEMBL20746353

SCHEMBL20746353

CCOC(=O)c1c(C=O)c2sc(SS(C)(=O)=O)nc2n1-c1nccs1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
MAPK1 P28482 1/20 0.33
ALDH1A1 P00352 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
PKM P14618 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
HPGD P15428 2/20 0.31
HSD17B10 Q99714 2/20 0.31
GAA P10253 2/20 0.31
MAPT P10636 2/20 0.31
ALOX15 P16050 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20745576 0.90 LMNA (0.41) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL20745728 0.76 LMNA (0.41) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL20745518 0.71 ALDH1A1 (0.47) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL20745512 0.69 LMNA (0.54) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL25019676 0.68 MAPK1 (0.34) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL20745593 0.68 LMNA (0.45) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL20746532 0.67 SMN1; SMN2 (0.45) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL31338415 0.66 LMNA (0.50) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL20745714 0.65 LMNA (0.42) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2
SCHEMBL20745645 0.64 ALDH1A1 (0.44) KDM4ELMNAMAPK1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668881-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS Agios Pharmaceuticals, Inc. (US) 2020-06-24 EP disclosed
WO-2019035863-A1 PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS AGIOS PHARMACEUTICALS, INC. (US) 2019-02-21 WO disclosed